Literature DB >> 30460453

A remark on: do all the European surgeons perform the same D2? The need for D2 audit in Europe.

Dezső Tóth1.   

Abstract

Mesh：

Year:  2018        PMID： 30460453     DOI： 10.1007/s13304-018-0608-3

Source DB:  PubMed          Journal:  Updates Surg        ISSN： 2038-131X


× No keyword cloud information.
  8 in total

1.  [Role of a computer program in gastric cancer surgery - beyond the evidence].

Authors:  Dezső Tóth; Adrienn Bíró; Zsolt Kincses; Péter Árkosy; Miklós Török
Journal:  Magy Seb       Date:  2017-03

Review 2.  Do all the European surgeons perform the same D2? The need of D2 audit in Europe.

Authors:  Maria Bencivenga; Giuseppe Verlato; Valentina Mengardo; Jacopo Weindelmayer; William H Allum
Journal:  Updates Surg       Date:  2018-06-04

3.  Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer?

Authors:  Ahmet Bilici; Bala B O Ustaalioglu; Mahmut Gumus; Mesut Seker; Burcak Yilmaz; Umut Kefeli; Emre Yildirim; Berkant Sonmez; Taflan Salepci; Metin Kement; Alpaslan Mayadagli
Journal:  Onkologie       Date:  2010-02-16

4.  Does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer?

Authors:  Ibrahim Sakcak; Barış Doğu Yıldız; Fatih Mehmet Avşar; Saadet Akturan; Kemal Kilic; Erdal Cosgun; Enver O Hamamci
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

5.  Extracapsular lymph node spread: a new prognostic factor in gastric cancer.

Authors:  Hakan Alakus; Arnulf H Hölscher; Guido Grass; Eva Hartmann; Christian Schulte; Uta Drebber; Stephan E Baldus; Elfriede Bollschweiler; Ralf Metzger; Stefan P Mönig
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

6.  Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer.

Authors:  Alvaro Díaz de Liaño; Concepción Yarnoz; Rubén Aguilar; Cristina Artieda; Héctor Ortiz
Journal:  Gastric Cancer       Date:  2008-07-02       Impact factor: 7.370

7.  Low rates of loco-regional recurrence following extended lymph node dissection for gastric cancer.

Authors:  A Muratore; G Zimmitti; R Lo Tesoriere; A Mellano; P Massucco; L Capussotti
Journal:  Eur J Surg Oncol       Date:  2009-01-22       Impact factor: 4.424

8.  Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.

Authors:  M Degiuli; M Sasako; A Ponti; A Vendrame; M Tomatis; C Mazza; A Borasi; L Capussotti; G Fronda; M Morino
Journal:  Br J Surg       Date:  2014-01       Impact factor: 6.939
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.